Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13—AMBRA Study
Marina Elena Cazzaniga(Azienda Ospedaliera San Gerardo), Giorgio Mustacchi(University of Trieste), Filippo Giovanardi, Angela Denaro, Rita Chiari(Azienda Ospedaliera di Perugia), Emanuela Magnolfi(Accademia di Belle Arti di Frosinone), Michelino De Laurentiis(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Tinari(University of Chieti-Pescara), Anna Maria Mosconi(Azienda Ospedaliera di Perugia), Grazia Arpino(University of Naples Federico II), P. Pronzato(Accademia Nazionale dei Lincei), Vanesa Gregorc(IRCCS Ospedale San Raffaele), Anna Maria Vandone(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Alessandra Beano(Presidio Ospedaliero), Raffaella Palumbo(Fondazione Salvatore Maugeri), Alessandra Gennari(Ente Ospedaliero Ospedali Galliera), Lorenzo Livi(European Society for Sexual Medicine), Francesco Ferraù(Université Paris-Sud), Giancarlo Bisagni, Laura Biganzoli(Hospital of Prato), Carlo Putzu(Institute of Oncology Research), Giuseppe Tonini(Campus Bio Medico University Hospital), Francesco Atzori(Azienda Ospedaliero-Universitaria Cagliari), Simon Spazzapan(Centro di Riferimento Oncologico), Livio Blasi, Francesco Giotta(Istituto Tumori Bari), Daniele Farci, Elena Fiorio(University of Verona), D. Amoroso(Ospedale Versilia), Pierosandro Tagliaferri(Magna Graecia University), Alessandra Fabi(Agostino Gemelli University Polyclinic), Giuseppina Rosaria Rita Ricciardi, Alessia D’Alonzo(Ospedale Policlinico San Martino), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Palma Pugliese(Ospedale Sant'Anna), Laura Scortichini
Cited by 0
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k